Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-25-032526
Filing Date
2025-06-23
Accepted
2025-06-23 08:12:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 xforprospectussupplement06.htm 424B5 420219
2 image_0.jpg GRAPHIC 3709
3 x4logo.jpg GRAPHIC 6333
  Complete submission text file 0001628280-25-032526.txt   435419
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-273961 | Film No.: 251063014
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)